Patents by Inventor John Fulkerson

John Fulkerson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210259367
    Abstract: An outsole for an article of footwear includes a plantar surface and a peripheral surface surrounding the plantar surface. The outsole for an article of footwear also includes an annular cleat set including a first plurality of traction elements arranged in series about a central axis on the plantar surface. The outsole for an article of footwear further includes one or more radial cleat sets each including a second plurality of the traction elements aligned along a respective radial axis intersecting the central axis. At least one of the second plurality of the traction elements includes a peripheral cleat formed on the peripheral surface.
    Type: Application
    Filed: February 23, 2021
    Publication date: August 26, 2021
    Applicant: NIKE, Inc.
    Inventors: Mike Ekstrom, Elizabeth Fulkerson, Michael J. Hass, John Hlavacs, Ethan Lee, Ricardo Salinas, JR., Darlan Zacharia
  • Patent number: 11026822
    Abstract: One preferred embodiment includes a stent delivery system including a retractable sheath and an outer stability sheath. The stability sheath freely rotates relative to the retractable sheath, relieving compression forces caused by twisting of stability sheath in when in a tortuous conformation.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: June 8, 2021
    Assignee: C. R. Bard, Inc.
    Inventors: Teodoro S. Jimenez, Jr., John Fulkerson, Raffaele Mazzei
  • Publication number: 20210128184
    Abstract: A retrieval device can include inwardly facing protruding features that facilitate engagement and capture of a thrombus or other mass from a body lumen of a patient. The protruding features can deploy from a frame of the retrieval device to extend radially inwardly toward an opposing side of the frame. When deployed into a thrombus, the protruding features engage and urge the thrombus as the retrieval device moves to facilitate capture.
    Type: Application
    Filed: October 30, 2020
    Publication date: May 6, 2021
    Inventors: John Fulkerson, Isa Rizk, Jihad Ali Mustapha, Teodoro S. Jimenez, JR., Patrick LO
  • Publication number: 20210128330
    Abstract: A stent can include outwardly facing protruding features that facilitate engagement with a wall of a body vessel. The protruding features can deploy from a frame of the stent to extend radially outwardly. When deployed into a body vessel, the protruding features engage and anchor against the wall of the body vessel to ensure accurate and secure placement of the stent.
    Type: Application
    Filed: November 4, 2020
    Publication date: May 6, 2021
    Inventors: John Fulkerson, Isa Rizk, Jihad Ali Mustapha, Teodoro S. Jimenez, JR.
  • Patent number: 10995905
    Abstract: A pressurized gaseous and liquified hydrocarbon feedstock storage system method. The system includes a plurality of underground circuits or sections having parallel pipes joined together by radial ends arranged in various configurations to minimize plot space and maximize the amount of pressurized gaseous fuel stored.
    Type: Grant
    Filed: December 13, 2019
    Date of Patent: May 4, 2021
    Assignee: FIREFLY ENERGY SERVICES, LLC
    Inventors: Jeff Oliver, Brent Smith, Rick Fizer, Kevin Murphy, John Fulkerson, Aleisha M. Marty
  • Publication number: 20210077116
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Application
    Filed: November 16, 2020
    Publication date: March 18, 2021
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Publication number: 20210046279
    Abstract: A delivery device can be provided with a low outer profile and high flexibility for navigating tortuous anatomy. An inner lumen defined by a shaft of the delivery device provides adequate space for delivery devices to target anatomy. Additionally, the delivery device maintains the patency of its lumen even when positioned within tortuous anatomy. The turns of filar(s) forming a coil of the shaft adjust their axial spacing relative to each other to avoiding buckling that would otherwise result in a narrowing of the inner lumen.
    Type: Application
    Filed: August 13, 2020
    Publication date: February 18, 2021
    Inventors: Outhit Bouasaysy, Isa Rizk, John Fulkerson
  • Publication number: 20210045757
    Abstract: A delivery system can be provided with an ability to change its configurations to achieve both access to target anatomy and treatment thereof. Such treatments can include directing interventional devices around an occlusion. By providing different functionality at different stages, the need to exchange and replace tools at different stages can be reduced or eliminated. Accordingly, such operations can be completed more rapidly, efficiently, and safely.
    Type: Application
    Filed: August 13, 2020
    Publication date: February 18, 2021
    Inventors: Outhit Bouasaysy, John Fulkerson, Isa Rizk, Fadi Saab
  • Patent number: 10835257
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: November 17, 2020
    Assignee: COVIDIEN LP
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Patent number: 10799255
    Abstract: Methods for treating a patient using intravascular devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to an intravascular device having an elongated member coupled to and extending between a handle and an angled distal portion. The distal portion is moveable between a first configuration having a first shape configured for intravascular delivery and a second configuration having a second shape, different than the first shape, that is configured for intravascular delivery.
    Type: Grant
    Filed: August 27, 2014
    Date of Patent: October 13, 2020
    Assignee: REFLOW MEDICAL, INC.
    Inventors: Isa Rizk, John Fulkerson, Mahmood Razavi
  • Publication number: 20200315826
    Abstract: One preferred embodiment includes a stent delivery system including a retractable sheath and an outer stability sheath. The stability sheath freely rotates relative to the retractable sheath, relieving compression forces caused by twisting of stability sheath in when in a tortuous conformation.
    Type: Application
    Filed: March 29, 2017
    Publication date: October 8, 2020
    Inventors: Teodoro S. Jimenez, JR., John Fulkerson, Raffaele Mazzei
  • Publication number: 20200107947
    Abstract: Delivery systems for expandable elements, such as stents or scaffolds having spikes, flails, or other protruding features for penetrating target tissue and/or delivering drugs within a human patient are described along with associated methods for using such systems. The delivery systems can be provided with a stent that is positioned over an inflatable balloon for expansion and delivery of the stent to a target delivery location. By positioning the stent over and about the inflatable balloon, the stent is ready to be expanded by the balloon immediately upon unsheathing with respect to the outer shaft. Additionally or alternatively, a stent can be positioned in an axially offset arrangement with respect to a balloon to reduce the need for space required by overlapping components.
    Type: Application
    Filed: October 4, 2019
    Publication date: April 9, 2020
    Inventors: Teodoro S. Jimenez, JR., Patrick Lo, John Fulkerson, Isa Rizk, Francisco Aguayo, Jihad Ali Mustapha, Gary Ansel
  • Publication number: 20190388108
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Application
    Filed: September 5, 2019
    Publication date: December 26, 2019
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Patent number: 10413310
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: September 17, 2019
    Assignee: Covidien LP
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Publication number: 20190201219
    Abstract: Expandable elements having drug-delivery features and associated systems and methods are disclosed herein. In one embodiment, a drug-eluting stent includes a radially expandable cylindrical frame having a plurality of struts. The frame is transformable between a low-profile delivery state and an expanded deployed state. A plurality of drug-delivery features are carried by one of the struts and configured to deliver a drug to a treatment site within the patient or piercing through the tissue wall to break the constricting of the vessel wall inwardly. When the frame is in the expanded state within a body lumen of the patient, the drug-delivery features extend radially outwardly away from the strut and are configured to engage and, in some arrangements, pass through a wall of the body lumen.
    Type: Application
    Filed: March 6, 2019
    Publication date: July 4, 2019
    Inventors: John Fulkerson, Isa Rizk, Jihad Ali Mustapha, Teodoro S. Jimenez
  • Patent number: 10258487
    Abstract: Expandable elements having drug-delivery features and associated systems and methods are disclosed herein. In one embodiment, a drug-eluting stent includes a radially expandable cylindrical frame having a plurality of struts. The frame is transformable between a low-profile delivery state and an expanded deployed state. A plurality of drug-delivery features are carried by one of the struts and configured to deliver a drug to a treatment site within the patient or piercing through the tissue wall to break the constricting of the vessel wall inwardly. When the frame is in the expanded state within a body lumen of the patient, the drug-delivery features extend radially outwardly away from the strut and are configured to engage and, in some arrangements, pass through a wall of the body lumen.
    Type: Grant
    Filed: March 27, 2017
    Date of Patent: April 16, 2019
    Assignee: REFLOW MEDICAL, INC.
    Inventors: John Fulkerson, Isa Rizk, Jihad Ali Mustapha, Teodoro S. Jimenez, Jr.
  • Publication number: 20190029692
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Application
    Filed: October 1, 2018
    Publication date: January 31, 2019
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Patent number: 10172729
    Abstract: Expandable elements having drug-delivery features and associated systems and methods are disclosed herein. In one embodiment, a drug-eluting stent includes a radially expandable cylindrical frame having a plurality of struts. The frame is transformable between a low-profile delivery state and an expanded deployed state. A plurality of drug-delivery features are carried by one of the struts and configured to deliver a drug to a treatment site within the patient or piercing through the tissue wall to break the constricting of the vessel wall inwardly. When the frame is in the expanded state within a body lumen of the patient, the drug-delivery features extend radially outwardly away from the strut and are configured to engage and, in some arrangements, pass through a wall of the body lumen.
    Type: Grant
    Filed: October 12, 2016
    Date of Patent: January 8, 2019
    Assignee: REFLOW MEDICAL, INC.
    Inventors: John Fulkerson, Isa Rizk, Jihad Ali Mustapha, Teodoro S. Jimenez, Jr.
  • Patent number: 10123803
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Grant
    Filed: June 29, 2011
    Date of Patent: November 13, 2018
    Assignee: COVIDIEN LP
    Inventors: David A. Ferrera, Andrew H. Cragg, John Fulkerson
  • Publication number: 20180305416
    Abstract: Recombinant Mycobacteria (rMyc) which contain sequences encoding a heparin-binding hemagglutinin (HBHA) fission protein are provided, as are methods of making and using the rMyc and the fusion protein. The fusion protein includes an amino terminal mycobacterial antigen Ag85B leader peptide and transcription of the fusion protein is driven by an Ag85B promoter sequence. The recombinant fusion protein is produced in abundance by the rMyc, is post-translationally methylated, and is highly antigenic.
    Type: Application
    Filed: November 30, 2017
    Publication date: October 25, 2018
    Inventors: John Fulkerson, Michael Brennan, Kamalakannan Velmurugan, Camille Locht